DE1217375B - Process for the production of 4-alkylthio-testosterone or -19-nortestosterone derivatives - Google Patents
Process for the production of 4-alkylthio-testosterone or -19-nortestosterone derivativesInfo
- Publication number
- DE1217375B DE1217375B DENDAT1217375D DE1217375DA DE1217375B DE 1217375 B DE1217375 B DE 1217375B DE NDAT1217375 D DENDAT1217375 D DE NDAT1217375D DE 1217375D A DE1217375D A DE 1217375DA DE 1217375 B DE1217375 B DE 1217375B
- Authority
- DE
- Germany
- Prior art keywords
- testosterone
- hydrogen atom
- group
- carbon atoms
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 8
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims description 15
- 125000004432 carbon atoms Chemical group C* 0.000 claims description 11
- 125000003545 alkoxy group Chemical group 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 229910052751 metal Inorganic materials 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 239000004215 Carbon black (E152) Substances 0.000 claims description 2
- 125000002252 acyl group Chemical group 0.000 claims description 2
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 125000004414 alkyl thio group Chemical group 0.000 claims description 2
- 125000000304 alkynyl group Chemical group 0.000 claims description 2
- 125000004185 ester group Chemical group 0.000 claims description 2
- 229910052731 fluorine Inorganic materials 0.000 claims description 2
- 125000001153 fluoro group Chemical group F* 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 230000000875 corresponding Effects 0.000 claims 1
- YZCKVEUIGOORGS-UHFFFAOYSA-N hydrogen atom Chemical compound [H] YZCKVEUIGOORGS-UHFFFAOYSA-N 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 25
- -1 2-ethylhexyl Chemical group 0.000 description 24
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 20
- 239000000243 solution Substances 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- LSDPWZHWYPCBBB-UHFFFAOYSA-N methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- IDWOPWCPFXYGDU-FBPKJDBXSA-N BrC1=C2CC[C@@H]3[C@H](CC[C@@]4([C@H](CC[C@H]43)O)C)[C@]2(CCC1=O)C Chemical compound BrC1=C2CC[C@@H]3[C@H](CC[C@@]4([C@H](CC[C@H]43)O)C)[C@]2(CCC1=O)C IDWOPWCPFXYGDU-FBPKJDBXSA-N 0.000 description 3
- RXXBBHGCAXVBES-XMUHMHRVSA-N Oxymesterone Chemical compound C1CC2=C(O)C(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@](C)(O)[C@@]1(C)CC2 RXXBBHGCAXVBES-XMUHMHRVSA-N 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N (3β)-Cholest-5-en-3-ol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- BDFAOUQQXJIZDG-UHFFFAOYSA-N 2-methylpropane-1-thiol Chemical compound CC(C)CS BDFAOUQQXJIZDG-UHFFFAOYSA-N 0.000 description 2
- WQAQPCDUOCURKW-UHFFFAOYSA-N Butanethiol Chemical compound CCCCS WQAQPCDUOCURKW-UHFFFAOYSA-N 0.000 description 2
- KCZCIYZKSLLNNH-FBPKJDBXSA-N Clostebol Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1Cl KCZCIYZKSLLNNH-FBPKJDBXSA-N 0.000 description 2
- DNJIEGIFACGWOD-UHFFFAOYSA-N Ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 2
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N Propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 2
- RMBAVIFYHOYIFM-UHFFFAOYSA-M Sodium methanethiolate Chemical compound [Na+].[S-]C RMBAVIFYHOYIFM-UHFFFAOYSA-M 0.000 description 2
- 229960003604 Testosterone Drugs 0.000 description 2
- WNUBDFJMQBMNQB-DXODLALXSA-N [(8R,9S,10R,13S,14S,17S)-4-chloro-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] propanoate Chemical compound C1CC2=C(Cl)C(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CC)[C@@]1(C)CC2 WNUBDFJMQBMNQB-DXODLALXSA-N 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 230000001195 anabolic Effects 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- CMKBCTPCXZNQKX-UHFFFAOYSA-N cyclohexanethiol Chemical compound SC1CCCCC1 CMKBCTPCXZNQKX-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N n-butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L na2so4 Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 2
- 230000000699 topical Effects 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- 150000000319 19-nortestosterones Chemical class 0.000 description 1
- ZMRFRBHYXOQLDK-UHFFFAOYSA-N 2-phenylethanethiol Chemical compound SCCC1=CC=CC=C1 ZMRFRBHYXOQLDK-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- 229940107161 Cholesterol Drugs 0.000 description 1
- VTXVGVNLYGSIAR-UHFFFAOYSA-N DECANE-1-THIOL Chemical compound CCCCCCCCCCS VTXVGVNLYGSIAR-UHFFFAOYSA-N 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- GUBGYTABKSRVRQ-UUNJERMWSA-N Lactose Natural products O([C@@H]1[C@H](O)[C@H](O)[C@H](O)O[C@@H]1CO)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 GUBGYTABKSRVRQ-UUNJERMWSA-N 0.000 description 1
- SUVIGLJNEAMWEG-UHFFFAOYSA-N Propanethiol Chemical compound CCCS SUVIGLJNEAMWEG-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 230000001548 androgenic Effects 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- WVDYBOADDMMFIY-UHFFFAOYSA-N cyclopentanethiol Chemical compound SC1CCCC1 WVDYBOADDMMFIY-UHFFFAOYSA-N 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 235000015244 frankfurter Nutrition 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 230000003152 gestagenic Effects 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 125000006217 methyl sulfide group Chemical group [H]C([H])([H])S* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N o-xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003204 osmotic Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000001184 potassium carbonate Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002335 preservative Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- KJRCEJOSASVSRA-UHFFFAOYSA-N propane-2-thiol Chemical compound CC(C)S KJRCEJOSASVSRA-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 150000003515 testosterones Chemical class 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 125000005023 xylyl group Chemical group 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Description
DEUTSCHESGERMAN
PATENTAMTPATENT OFFICE
AUSLEGESCHRIFTEDITORIAL
Int. Cl.:Int. Cl .:
C07cC07c
Deutsche Kl.: 12 ο-25/04 German class: 12 ο -25/04
Nummer: 1 217 375Number: 1 217 375
Aktenzeichen: M 53914IV b/12 οFile number: M 53914IV b / 12 ο
Anmeldetag: 16. August 1962Filing date: August 16, 1962
Auslegetag: 26. Mai 1966Opening day: May 26, 1966
Es wurde gefunden, daß eine Reihe von neuen schwefelhaltigen Derivaten der Testosteron- bzw. 19-nor-Testosteronreihe der allgemeinen Formel IIt has been found that a number of new sulfur-containing derivatives of testosterone or 19-nor-testosterone series of general formula I.
R5 R 5
R3 R 3
worin Ri ein Wasserstoffatom oder eine Alkyl- oder Alkoxygruppe mit jeweils 1 bis 3 Kohlenstoffatomen, R2 ein Wasserstoffatom oder eine Alkyl- oder Alkoxygruppe mit jeweils 1 bis 3 Kohlenstoffatomen, R3 ein Wasserstoffatom oder eine Alkyl-, Alkoxy- oder Alkylthiogruppe mit jeweils 1 bis 3 Kohlenstoffatomen, R4 ein Wasserstoff- oder Fluoratom, R5 ein Wasserstoffatom oder eine Hydroxylgruppe, Re ein Wasserstoffatom oder eine Alkyl-, Alkenyl- oder Alkinylgruppe mit jeweils 1 bis 3 Kohlenstoffatomen, R7 ein Wasserstoffatom oder eine Acylgruppe, Rs ein Wasserstoffatom oder eine Methylgruppe, R9 einen Kohlenwasserstoffrest mit 1 bis 10 Kohlenstoffatomen bedeutet, sehr gute anabole bzw. gestagene Eigenschaften besitzen. Insbesondere zeigen sie einen erhöhten Index von anaboler zu androgener Wirksamkeit. wherein Ri is a hydrogen atom or an alkyl or alkoxy group each having 1 to 3 carbon atoms, R2 is a hydrogen atom or an alkyl or alkoxy group each having 1 to 3 carbon atoms, R3 Hydrogen atom or an alkyl, alkoxy or alkylthio group each with 1 to 3 carbon atoms, R4 is a hydrogen or fluorine atom, R5 is a hydrogen atom or a hydroxyl group, Re is Hydrogen atom or an alkyl, alkenyl or alkynyl group each with 1 to 3 carbon atoms, R7 is a hydrogen atom or an acyl group, Rs is a hydrogen atom or a methyl group, R9 is a Hydrocarbon radical with 1 to 10 carbon atoms means very good anabolic or gestagenic Possess properties. In particular, they show an increased index of anabolic to androgenic effectiveness.
Verfahren zur Herstellung von 4-Alkylthiotestosteron- bzw. -19-nor-testosteronderivatenProcess for the preparation of 4-alkylthiotestosterone or -19-nor-testosterone derivatives
Anmelder:Applicant:
E. Merck Aktiengesellschaft,
Darmstadt, Frankfurter Str. 250E. Merck Aktiengesellschaft,
Darmstadt, Frankfurter Str. 250
Als Erfinder benannt:
Dipl.-Chem. Dr. Josef Krämer,
Dipl.-Chem. Dr. Klaus Irmscher, DarmstadtNamed as inventor:
Dipl.-Chem. Dr. Josef Kramer,
Dipl.-Chem. Dr. Klaus Irmscher, Darmstadt
Gegenstand der Erfindung ist ein Verfahren zur Herstellung von 4-Alkylthio-testosteron- bzw. -19-nor-Testosteronderivaten der allgemeinen Formel I.The invention relates to a process for the production of 4-alkylthio-testosterone or -19-nor-testosterone derivatives of the general formula I.
Nach dem Verfahren der Erfindung werden diese neuen Verbindungen hergestellt, indem man ein entsprechendes zl4-3-Keto-steroid, das in 4-Stellung durch eine Hydroxylgruppe oder durch Chlor oder Brom substituiert ist, mit einem Mercaptan der allgemeinen Formel R9SH, worin R9 die vorstehend angegebene Bedeutung hat, oder mit einem entsprechenden Metallmercaptid in Lösung nach folgendem Reaktionsschema umsetzt, in welchem der Übersichtlichkeit halber nur der unsubstituierte Ring A eines sonst der Formel I entsprechenden Steroids dargestellt ist,According to the process of the invention, these new compounds are prepared by adding a corresponding zl 4 -3-keto-steroid, which is substituted in the 4-position by a hydroxyl group or by chlorine or bromine, with a mercaptan of the general formula R 9 SH, wherein R9 has the meaning given above, or reacts with a corresponding metal mercaptide in solution according to the following reaction scheme, in which, for the sake of clarity, only the unsubstituted ring A of a steroid otherwise corresponding to formula I is shown,
R9SH + bzw. R9SMeR 9 SH + or R 9 SMe
(X = OH, Cl, Br x (X = OH, Cl, Br x
Me = Alkali- oder Erdalkalimetall)Me = alkali or alkaline earth metal)
und daß man gegebenenfalls in an sich bekannter Weise eine in 17-Stellung der erhaltenen Verbindung vorhandene Hydroxygruppe verestert bzw. eine an dieser Stelle befindliche Estergruppe verseift.and that, if appropriate, in a manner known per se, one in the 17-position of the compound obtained existing hydroxyl group is esterified or an ester group located at this point is saponified.
Verfahrensgemäß kann man so arbeiten, daß man, gegebenenfalls unter Kühlung, das Metallmercaptid durch Zugeben des Mercaptans zu einer methanolischen oder äthanolischen Metallalkoholatlösung bereitet, dann das Steroid als solches oder gelöst in einem inerten Lösungsmittel zusetzt und anschließendAccording to the process, one can work in such a way that, if appropriate with cooling, the metal mercaptide prepared by adding the mercaptan to a methanolic or ethanolic metal alcoholate solution, then the steroid as such or dissolved in an inert solvent is added and then
bis zur Beendigung der Umsetzung stehenläßt oder erhitzt. Man kann aber auch das Mercaptan als solches oder in einem inerten Lösungsmittel gelöst zu einer Lösung oder Suspension des Steroids zufügen. Geeignete Lösungsmittel sind beispielsweise Alkohole, wie Methanol, Äthanol, Isopropanol, tert. Butanol, Kohlenwasserstoffe, wie Benzol, Toluol, Xylol, Äther, Tetrahydrofuran, Dioxan. Gegenwart von Luft oder Wasser schadet prinzipiell nicht, jedoch sind die Ausbeuten beim Arbeiten unter Sauerstoff-left to stand or heated until the reaction has ended. But you can also use the mercaptan as add such or dissolved in an inert solvent to a solution or suspension of the steroid. Suitable solvents are, for example, alcohols such as methanol, ethanol, isopropanol, tert. Butanol, hydrocarbons such as benzene, toluene, xylene, ether, tetrahydrofuran, dioxane. presence of air or water does not harm in principle, but the yields when working under oxygen
609 570/578609 570/578
ausschluß höher, besonders, wenn die verwendeten Lösungsmittel unter Durchblasen von reinem und trockenem Stickstoff ausgekocht sind. Bei Reaktionen mit den niederen, leichtflüchtigen Mercaptanen kann es vorteilhaft sein, während der Reaktion unter Druck zu arbeiten.exclusion higher, especially if the solvent used is blown with pure and boiled dry nitrogen. In reactions with the lower, volatile mercaptans it can be advantageous to work under pressure during the reaction.
Von den für das erfindungsgemäße Verfahren geeigneten Ausgangsmaterialien seien beispielsweise genannt: 4-Hydroxy-, 4-Chlor- oder 4-Brom-testosteron, 4 - Brom - 17a - äthinyl -19 - nor - testosteron, 4 - Chlor - testosteron - 17 - benzoat, 4 - Hydroxy-7-äthoxy-19-nor-testosteron-17-propionat. Als Mer-Examples of the starting materials suitable for the process according to the invention are: 4-hydroxy-, 4-chloro- or 4-bromine-testosterone, 4 - bromine - 17a - äthinyl -19 - nor - testosterone, 4 - chlorine - testosterone - 17 - benzoate, 4 - hydroxy-7-ethoxy-19-nor-testosterone-17-propionate. As a mer-
IO captane sind in freier Form oder als Metallmercaptide beispielsweise die folgenden geeignet: Methyl-, Äthyl-, Propyl-, Isopropyl-, Butyl-, Isobutyl-, sek. Butyl-, tert. Butyl-, Amyl-, Isoamyl-, Hexyl-, Heptyl-, Octyl-, Nonyl-, Decyl-, 2-Äthylhexyl-, Allyl-, Propargyl-, Cyclopentyl-, Cyclohexyl-, Phenyl-, o-Tolyl-, m-To-IyI-, p-Tolyl-, p-Äthylphenyl-, Xylyl-, Mesityl-, a-Naphthyl-, /5-Naphthyl-, Benzyl-, α-Phenyläthyl-, ß-Phenyläthylmercaptan. IO captans are suitable in free form or as metal mercaptides, for example, the following: methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec. Butyl, tert. Butyl, amyl, isoamyl, hexyl, heptyl, octyl, nonyl, decyl, 2-ethylhexyl, allyl, propargyl, cyclopentyl, cyclohexyl, phenyl, o-tolyl, m -To-IyI-, p-tolyl-, p-ethylphenyl-, xylyl-, mesityl-, a-naphthyl-, / 5-naphthyl-, benzyl-, α-phenylethyl, ß-phenylethyl mercaptan.
Im einzelnen haben sich Verfahrensprodukte der nachstehenden Formeln als besonders wirksam erwiesen:In particular, process products of the formulas below have proven to be particularly effective proven:
4545
Ri bis R7 haben die oben angegebene Bedeutung; Rg kann seinRi to R7 have the meaning given above; Rg can be
a) ein aliphatischer geradkettiger oder verzweigter Rest,a) an aliphatic straight-chain or branched residue,
b) ein cycloaliphatischer Rest,b) a cycloaliphatic radical,
c) ein araliphatischer Rest,c) an araliphatic residue,
d) ein aromatischer Rest mit jeweils bis zu 10 Kohlenstoffatomen. d) an aromatic radical with up to 10 carbon atoms each.
Die neuen, verfahrensgemäß erhaltenen Verbindungen können im Gemisch mit üblichen Arzneimitteltfägern in der Human- und Veterinärmedizin eingesetzt werden. Als Trägersubstanzen kommen solche organische oder anorganische Stoffe in Frage, die für die parenterale, enterale oder topikale Applikation geeignet sind und die mit den neuen Verbindungen nicht in Reaktion treten, wie beispielsweise Wasser, pflanzliche öle, Polyäthylenglykole, Gelatine, Milchzucker, Stärke, Magnesiumstearat, Talk, Vaseline, Cholesterin usw. Zur parenteralen Applikation dienen insbesondere Lösungen, vorzugsweise ölige oder wäßrige Lösungen, sowie Suspensionen, Emulsionen oder Implantate. Für die enterale Applikation sind Tabletten· oder Dragees, für die topikale Anwendung Salben oder Cremes geeignet, die gegebenenfalls sterilisiert oder mit Hilfsstoffen, wie Konservierungs-, Stabilisierungs- oder Netzmitteln oder Salzen zur Beeinflussung des osmotischen Druckes, oder mit Puffersubstanzen versetzt sind. .The new compounds obtained according to the process can be mixed with conventional medicament carriers used in human and veterinary medicine. Come as carrier substances those organic or inorganic substances in question which are for parenteral, enteral or topical application are suitable and do not come into reaction with the new compounds, such as Water, vegetable oils, polyethylene glycols, gelatine, lactose, starch, magnesium stearate, talc, petroleum jelly, Cholesterol, etc. Solutions, preferably oily, are used in particular for parenteral administration or aqueous solutions, as well as suspensions, emulsions or implants. For enteral application are tablets · or dragees, ointments or creams suitable for topical application, if necessary sterilized or with auxiliaries such as preservatives, stabilizers or wetting agents or salts to influence the osmotic pressure, or are mixed with buffer substances. .
Die erfindungsgemäß hergestellten Verbindungen werden vorzugsweise in einer Dosierung von 1 bis R-The compounds prepared according to the invention are preferably used in a dosage of 1 to R-
R3 R 3
10 mg bei oraler, von 10 bis 100 mg bei parenteraler Gabe verwendet.10 mg for oral use, from 10 to 100 mg for parenteral use Gift used.
12,0 g 4-Chlor-testosteron, gelöst in 100 ml absolutem Äthanol, werden zu einer durch Auflösen von 5 g Natrium in 200 ml absolutem Äthanol in Luft unter Feuchtigkeitsausschluß und Zugabe von 12,4 g Äthylmercaptan hergestellten Lösung von Natriumäthylmercaptid langsam zugetropft. Das Reaktionsgemisch wird anschließend 5 Stunden unter Rückfluß gekocht, das Lösungsmittel hierauf im Vakuum abgezogen, der Rückstand mit Wasser versetzt und mit Chloroform extrahiert. Anschließend wird der Extrakt gewaschen, getrocknet, das Chloroform abdestilliert und der aus 4-Äthylmercapto-testosteron bestehende Rückstand aus Äther umkristallisiert. Fp. 146 bis 1470C; [a]f = +120° (Chloroform); lmax = 247 ΐημ, Eil = 321 und 312 ηΐμ, Eil = 61 (Äthanol).12.0 g of 4-chloro-testosterone, dissolved in 100 ml of absolute ethanol, are slowly added dropwise to a solution of sodium ethyl mercaptide prepared by dissolving 5 g of sodium in 200 ml of absolute ethanol in air with exclusion of moisture and adding 12.4 g of ethyl mercaptan. The reaction mixture is then refluxed for 5 hours, the solvent is then stripped off in vacuo, the residue is mixed with water and extracted with chloroform. The extract is then washed and dried, the chloroform is distilled off and the residue consisting of 4-ethylmercapto-testosterone is recrystallized from ether. M.p. 146 to 147 ° C; [a] f = + 120 ° (chloroform); l max = 247 ΐημ, Eil = 321 and 312 ηΐμ, Eil = 61 (ethanol).
Analog werden, ausgehend von 1,5 g 4-Bromtestosteron und 1,4 g Propylmercaptan, 0,6 g 4-Propylmercapto-testosteron erhalten. lmax — 247 πΐμ, EU = 315; Xmax = 310 πΐμ, Eil = 60.Analogously, starting from 1.5 g of 4-bromestosterone and 1.4 g of propyl mercaptan, 0.6 g of 4-propyl mercapto testosterone is obtained. l ma x - 247 πΐμ, EU = 315; Xmax = 310 πΐμ, Eil = 60.
Bei Verwendung von 1,7 g Isobutylmercaptan und 1,5 g 4-Brom-testosteron als Ausgangsmaterial erhält man entsprechend 0,5 g 4-Isobutylniereaptotestosteron. /,„„.,· = 247,5 πΐμ, EJI = 320; lmax = 309 ηΐμ, EH= 60. ■When using 1.7 g of isobutyl mercaptan and 1.5 g of 4-bromo-testosterone as the starting material, 0.5 g of 4-isobutylniereaptotestosterone is obtained accordingly. /, ““. ,· = 247.5 πΐμ, EJI = 320; l max = 309 ηΐμ, EH = 60. ■
Auf analoge Weise werden, ausgehend von 1,9 g Cyclopentylmercaptan und 1,5 g 4-Brom-testosteron,In an analogous manner, starting from 1.9 g of cyclopentyl mercaptan and 1.5 g of 4-bromo-testosterone,
0,55 g 4-Cyclopentylmercapto-testosteron erhalten. Xmax = 245 πΐμ, E}1 = 312; Xmax = 308 m^, ^I cm = ·'"· 0.55 g of 4-cyclopentylmercapto-testosterone were obtained. Xmax = 245 πΐµ, E} 1 = 312; X max = 308 m ^, ^ I cm = · '"·
Mit Hilfe derselben Verfahrensweise werden ausUsing the same procedure, the
2.0 g Cyclohexylmercaptan und 1,5 g 4-Brom-testosteron 0,5 g 4-Cyclohexylmercapto-testosteron erhalten. Xmax = 246 mm EU = 313; Xmax = 308 mμ, EJl = 60,2.0 g of cyclohexyl mercaptan and 1.5 g of 4-bromo-testosterone and 0.5 g of 4-cyclohexyl mercapto-testosterone were obtained. X max = 246 mm EU = 313; X max = 308 mμ, EJl = 60,
rr
Analog Beispiel 1 wird aus 4-Hydroxy-17a-methyltestosteron und Äthylmercaptan 4-Äthylmercapto-17a-methyl-testosteron vom Fp. 144 bis 145°C hergestellt. [a]2i = +110° (Chloroform); Xmax = 247 πΐμ, EJl = 307; Xm,ix - 312 Γημ, EU = 61 (Äthanol).Analogously to Example 1, 4-ethylmercapto-17a-methyltestosterone with a melting point of 144 ° to 145 ° C. is prepared from 4-hydroxy-17a-methyltestosterone and ethyl mercaptan. [a] 2 i = + 110 ° (chloroform); X max = 247 πΐμ, EJl = 307; X m , ix - 312 Γημ, EU = 61 (ethanol).
Ausgehend von 1,6 g Isopropylmercaptan undStarting from 1.6 g of isopropyl mercaptan and
1.1 g 4-Hydroxy-17a-methyl-testosteron erhält man in analoger Weise 0,4 g 4-Isopropylmercapto-testosteron. Xmax = 247 πΐμ, EJl = 324; Xmax = 310 ηΐμ, EJl = 61.1.1 g of 4-hydroxy-17a-methyl-testosterone are obtained in an analogous manner, 0.4 g of 4-isopropylmercapto-testosterone. X ma x = 247 πΐμ, EJl = 324; X max = 310 ηΐμ, EJl = 61.
Auf analogem Wege werden bei Verwendung von 1,8 g Butylmercaptan und 1,1 g 4-Hydroxy-17a-methyl-testosteron als Ausgangsmaterial 0,5 g 4-Butylmercapto - testosteron erhalten. Xmax = 246 ταμ, EU = 318; Xmax = 311 ηΐμ, EJi = 59.In an analogous way, when using 1.8 g of butyl mercaptan and 1.1 g of 4-hydroxy-17a-methyl testosterone as starting material, 0.5 g of 4-butyl mercaptan testosterone is obtained. X max = 246 ταμ, EU = 318; Xmax = 311 ηΐμ, EJi = 59.
12,0 g 4-Chlor-testosteron, gelöst in 100 ml absolutem Äthanol, werden langsam zu einer durch Auflösen von 5 g Natrium in 200 ml absolutem Äthanol in Luft unter Feuchtigkeitsausschluß und Zugabe von 10,5 g Methylmercaptan hergestellten Lösung von Natriummethylmercaptid zugetropft. Das Reaktionsgemisch wird anschließend 3 Stunden unter Rückfluß gekocht und hierauf, wie im Beispiel 1 angegeben, aufgearbeitet. Das erhaltene 4-Methylmercapto-testosteron schmilzt bei 138 bis 139°C. [a]ls = +156° (Chloroform); Xmax = 246πΐμ, EJl = 322; Xmax = 312 ΐημ, E}1 = 70 (Äthanol).12.0 g of 4-chloro-testosterone, dissolved in 100 ml of absolute ethanol, are slowly added dropwise to a solution of sodium methyl mercaptide prepared by dissolving 5 g of sodium in 200 ml of absolute ethanol in air with exclusion of moisture and adding 10.5 g of methyl mercaptan. The reaction mixture is then refluxed for 3 hours and then worked up as indicated in Example 1. The 4-methylmercapto-testosterone obtained melts at 138 to 139 ° C. [a] 1 s = + 156 ° (chloroform); X max = 246πΐμ, EJl = 322; Xmax = 312 ΐημ, E} 1 = 70 (ethanol).
Analog wird aus 4-Brom-17a-methyl-testosteron und Methylmercaptan 4-Methylmercapto-17a-methyl-testosteron hergestellt. Fp. 144 bis 145°C; [aYi = +102,3° (Chloroform); Xmax = 245 πΐμ, EJi = 318; Xmax = 310 mm E}1 = 96 (Äthanol).Analogously, 4-methylmercapto-17a-methyl-testosterone is produced from 4-bromo-17a-methyl-testosterone and methyl mercaptan. Mp 144-145 ° C; [aYi = + 102.3 ° (chloroform); X max = 245 πΐµ, EJi = 318; Xmax = 310 mm E} 1 = 96 (ethanol).
Analog erhält man, ausgehend von 2 g Cyclohexylmercaptan, durch Umsetzung mit 4-Brom-17a-methyl-testosteron 0,6 g 4-Cyclohexylmercapto-17a-methyl-testosteron. Xmax = 245 πΐμ, EJi = 315; Amax = 309 ηΐμ, EJi = 63.Analogously, starting from 2 g of cyclohexyl mercaptan, reaction with 4-bromo-17a-methyl-testosterone gives 0.6 g of 4-cyclohexylmercapto-17a-methyl-testosterone. X max = 245 πΐµ, EJi = 315; Amax = 309 ηΐμ, EJi = 63.
Auf analogem Weg werden aus 2,3 g n-Decylmercaptan durch Umsetzung mit 4-Brom-17a-methyltestosteron 0,3 g 4-n-Decylmercapto-17α-methyl-testosteron hergestellt. Xmax = 244 ηΐμ, EJI = 305; Xmax = 307 mm EJl = 58.In an analogous way, 0.3 g of 4-n-decylmercapto-17α-methyl-testosterone are produced from 2.3 g of n-decyl mercaptan by reaction with 4-bromo-17a-methyltestosterone. X max = 244 ηΐµ, EJI = 305; Xmax = 307 mm EJl = 58.
2,3 g 2-Methyl-4-chlor-testosteron, gelöst in 10 ml absolutem Äthanol, werden mit der erforderlichen Menge einer Lösung von Natriumäthylmercaptid in absolutem Äthanol analog Beispiel 1 umgesetzt und aufgearbeitet. Man erhält 0,7 g 2-Methyl-4-äthylmercapto-testosteron. Xmax = 245 ηΐμ, EJI = 320; Xmax = 310 ηΐμ, EU = 70.2.3 g of 2-methyl-4-chloro-testosterone, dissolved in 10 ml of absolute ethanol, are reacted with the required amount of a solution of sodium ethyl mercaptide in absolute ethanol as in Example 1 and worked up. 0.7 g of 2-methyl-4-ethylmercapto-testosterone are obtained. X ma x = 245 ηΐμ, EJI = 320; X max = 310 ηΐμ, EU = 70.
Analog werden, ausgehend von 1,6 g Isobutylmercaptan, durch Umsetzung mit 2-Methyl-4-chlortestosteron 0,4 g 2-Methyl-4-isobutylmercapto-testosteron erhalten. Xmax =■ 244 πΐμ, EJl = 305; Xmax = 309 Χημ, EJl = 65.Analogously, starting from 1.6 g of isobutyl mercaptan, reaction with 2-methyl-4-chlorotestosterone gives 0.4 g of 2-methyl-4-isobutylmercapto-testosterone. X max = ■ 244 πΐμ, EJl = 305; Xmax = 309 Χημ, EJl = 65.
1,2 g l-Methyl-4-chlor-testosteron werden mit der erforderlichen Menge Methylmercaptan in Natriumäthylat—Äthanol analog Beispiel 3 umgesetzt und aufgearbeitet. Aus Äthanol erhält man 0,6 g reines 1 - Methyl -A- methylmercapto - testosteron. Xmax = 241 τημ, EJi = 325; Xmax = 312 mm1.2 g of 1-methyl-4-chloro-testosterone are reacted with the required amount of methyl mercaptan in sodium ethylate-ethanol as in Example 3 and worked up. 0.6 g of pure 1-methyl- amethylmercapto -testosterone is obtained from ethanol. Xmax = 241 τηµ, EJi = 325; X max = 312 mm
6 g des nach Beispiel 1 erhaltenen 4-Äthylmercaptotestosterons werden in 30 ml trockenem Pyridin gelöst, mit 30 ml Propionsäureanhydrid versetzt und über Nacht stehengelassen. Das Reaktionsgemisch wird in Eiswasser eingerührt, neutralisiert und das abgeschiedene öl mit Chloroform extrahiert. Der Extrakt wird gründlich gewaschen und über Natriumsulfat getrocknet. Nach dem Abziehen des Lösungsmittels wird der Rückstand aus Methanol umkristallisiert. Man erhält 4-Äthylmercapto-testosteronpropionat vom Fp. 79 bis 800C; [a]f = +120° (Chloroform); Xmax = 247 ηΐμ, EU = 264; Xmax = 312 ηΐμ, Ε}! = 51 (Äthanol).6 g of the 4-ethylmercaptotestosterone obtained according to Example 1 are dissolved in 30 ml of dry pyridine, mixed with 30 ml of propionic anhydride and left to stand overnight. The reaction mixture is stirred into ice water, neutralized and the separated oil extracted with chloroform. The extract is washed thoroughly and dried over sodium sulfate. After the solvent has been stripped off, the residue is recrystallized from methanol. There is obtained 4-Äthylmercapto-testosterone propionate, mp 79-80 0 C. [a] f = + 120 ° (chloroform); X max = 247 ηΐµ, EU = 264; X max = 312 ηΐμ, Ε}! = 51 (ethanol).
Analog Beispiel 6 wird aus dem nach Beispiel 3 erhaltenen 4-Methylmercapto-testosteron und Propionsäureanhydrid in Pyridin das 4-Methylmercaptotestosteronpropionat hergestellt. Fp. 107°C; [a\2i = + 127,8° (Chloroform); Xmai=2A5 πΐμ, E]I=290; Xmax = 310 ηαμ, E}1 = 64 (Äthanol).Analogously to Example 6, 4-methylmercaptotestosterone propionate is prepared from the 4-methylmercaptotestosterone obtained according to Example 3 and propionic anhydride in pyridine. Mp 107 ° C; [a \ 2 i = + 127.8 ° (chloroform); X ma i = 2A5 πΐµ, E] I = 290; Xmax = 310 ηαμ, E} 1 = 64 (ethanol).
1 g des nach Beispiel 5 erhaltenen 1-Methyl-4-methylmercapto-testosterons wird in 5 ml trockenem Pyridin mit 5 g önanthsäureanhydrid 1 Stunde auf dem Dampfbad gekocht. Die Lösung wird hierauf abgekühlt und in Eiswasser eingerührt. Nach Extrahieren mit Chloroform und Waschen des Extrakts mit Wasser wird über Natriumsulfat getrocknet. Nach Abdestillieren des Lösungsmittels erhält man rohes l-Methyl-4-methylmercapto-testosteron-17-önanthat, das durch Umkristallisieren aus Äthanol gereinigt wird. Xmax = 243 πΐμ, E}1 = 310; Xmax = 306 Πΐμ, E]I = 59.1 g of the 1-methyl-4-methylmercapto-testosterone obtained according to Example 5 is boiled in 5 ml of dry pyridine with 5 g of önanthic anhydride for 1 hour on the steam bath. The solution is then cooled and stirred into ice water. After extracting with chloroform and washing the extract with water, it is dried over sodium sulfate. After the solvent has been distilled off, crude 1-methyl-4-methylmercapto-testosterone-17-oenanthate is obtained, which is purified by recrystallization from ethanol. X ma x = 243 πΐμ, E} 1 = 310; Xmax = 306 Πΐμ, E] I = 59.
1 g 4-Methylmercapto-testosteronpropionat (erhalten durch Umsetzung von äquimolekularen Mengen von 4-Chlor-testosteronpropionat und Natriummethylmercaptid analog Beispiel 3) wird in 5%iger wäßrig-äthanolischer Lösung von Kaliumcarbonat 1 Stunde unter Stickstoff am Rückfluß gekocht. Hierauf wird mit Wasser verdünnt, der Niederschlag abfiltriert und aus Äther umkristallisiert. Man erhält 0,6 g 4-Methylmercapto-testosteron vom Fp. 137 bis 1380C.1 g of 4-methylmercapto-testosterone propionate (obtained by reacting equimolecular amounts of 4-chloro-testosterone propionate and sodium methyl mercaptide as in Example 3) is refluxed in 5% aqueous-ethanolic solution of potassium carbonate for 1 hour under nitrogen. It is then diluted with water, the precipitate is filtered off and recrystallized from ether. 0.6 g of 4-methylmercapto-testosterone with a melting point of 137 to 138 ° C. is obtained.
Auf analoge Weise wird aus 4-Äthylmercaptotestosteronpropionat (erhalten durch Umsetzung von äquimolekularen Mengen von 4-Chlor-testosteronpropionat und Natriumäthylmercaptid analog Beispiel 3) 4-Äthylmercapto-testosteron vom Fp. 147 bis 1480C erhalten.In an analogous manner (obtained by reacting equimolecular amounts of 4-chloro-testosterone propionate and Natriumäthylmercaptid analogously to Example 3) 4-Äthylmercapto-testosterone, mp. 147 to 148 0 C obtained from 4-Äthylmercaptotestosteronpropionat.
Claims (1)
Publications (1)
Publication Number | Publication Date |
---|---|
DE1217375B true DE1217375B (en) | 1966-05-26 |
Family
ID=602431
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DENDAT1217375D Pending DE1217375B (en) | Process for the production of 4-alkylthio-testosterone or -19-nortestosterone derivatives |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE1217375B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0375559A1 (en) * | 1988-12-22 | 1990-06-27 | Roussel-Uclaf | Steroids containing an alkythio radical at position 4, process for their preparation, their use as medicaments and pharmaceutical compositions containing them |
-
0
- DE DENDAT1217375D patent/DE1217375B/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0375559A1 (en) * | 1988-12-22 | 1990-06-27 | Roussel-Uclaf | Steroids containing an alkythio radical at position 4, process for their preparation, their use as medicaments and pharmaceutical compositions containing them |
FR2640976A1 (en) * | 1988-12-22 | 1990-06-29 | Roussel Uclaf |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2359076C2 (en) | 2β, 16β-Dipiperidino-5α-androstanes and processes for their preparation | |
DE1217375B (en) | Process for the production of 4-alkylthio-testosterone or -19-nortestosterone derivatives | |
DE1198818B (en) | Process for the production of 2, 3-epithiosteroids | |
DE1222920B (en) | Process for the preparation of 19-methylene derivatives of the androstane series which are substituted in the 3-position by an oxygen-containing substituent | |
DE1232577B (en) | Process for the preparation of delta 4,9-3-oxo-11beta-hydroperoxy-19-nor-steroids | |
DE1215702B (en) | Process for the preparation of 1alpha-alkylthio-3-keto-androstanes | |
DE1204221B (en) | Process for the preparation of 7alpha-alkylthio-steroids | |
DE2244234C2 (en) | Process for the preparation of beta-mercaptopropionic acid and its esters | |
DE1593516B2 (en) | 4 halo-1,2alpha; 6,7beta-bismethylene-delta high 4-3-ketosteroids, processes for their preparation and compositions containing these steroids | |
AT271744B (en) | Process for the preparation of new methylostrenes | |
DE1243681B (en) | Process for the preparation of 4-mercapto derivatives of the testosterone or 19-nor-testosterone series and of S-alkyl and S-acyl derivatives of the same | |
DE1225638B (en) | Process for the preparation of 7alpha-alkylthio-17alpha-methyl-testosterones | |
AT259772B (en) | Process for the preparation of sulfur-containing pyridine derivatives | |
DE1793596C3 (en) | 13-alkyl-gona-1,3, (10) -trienes. Eliminated from: 1443123 | |
DE1254149B (en) | Process for the preparation of 1alpha, 7alpha-dialkylthio-3-keto-4-androstenes | |
DE1238016B (en) | Process for the preparation of S-alkylated or S-acylated 7alpha-mercapto-delta 1,4-3-keto-steroids | |
DE2419207C3 (en) | Process for the preparation of 3-hemisulphate-17alpha hydroxy steroids | |
CH532565A (en) | 9beta 10alpha-steroids progestatives | |
DE1443637A1 (en) | Process for the preparation of new 4-haloandrostenes | |
DE1196651B (en) | Process for the preparation of A4,6-3-oxo-19-hydroxysteroid dienes or derivatives thereof | |
DE1250433B (en) | Process for the production of Zl2 4 steroids of the Androstan- 19-Norandrostan Pregnan or 19 Norpregnan series | |
DE1227899B (en) | Process for the production of 4-acylthiotestosterones or -19-nor-testosterones and their 1-dehydro derivatives | |
DE1468354A1 (en) | Process for the production of 6 substituted 6-dehydro-progesterone derivatives | |
DE1198356B (en) | Process for the production of sulfur-containing androstane derivatives | |
DE1223378B (en) | Process for the preparation of 16beta-alkylthioestradiol methyl ether derivatives |